1. Ticagrelor: a P2Y12antagonist for use in acute coronary syndromes
2. AstraZeneca, Full-Year and Q4 2015 Results (press release), February 4, 2016.https://www.astrazeneca.com/media-centre/press-releases/2016/full-year-and-q4-2015-results-04022016.html(accessed August 24, 2016) .
3. AstraZeneca, AstraZeneca Issues Update on Strategy to Deliver Value to Shareholders (press release), May 6, 2014.https://www.astrazeneca.com/media-centre/press-releases/2014/astrazeneca-updated-strategy-value-for-shareholders-06052014.html(accessed August 24, 2016) .
4. Guile, S.; Hardern, D.; Ingall, A.; Springthorpe, B.; Willis, P.Novel Triazolo(4,5-d)pyrimidine Compounds. WO 0034283, June 15, 2000.
5. Guile, S.; Springthorpe, B.Novel [1,2,3]-Triazolo[4,5-d]pyrimidine Compounds. WO 2001036421A1, May 25, 2001.